post-infectious irritable bowel syndrome

临床试验

计划入组 131 人 · 首次发布于 2011 年 12 月 23 日

招募中

NCT07517029

Gut Microbiome in Patients With Post-infectious Irritable Bowel Syndrome

计划入组 315 人 · 首次发布于 2026 年 4 月 8 日

已完成

NCT01787253

Microbe-Gut Interaction in Microscopic Colitis and Post-Infectious Irritable Bowel Syndrome (IBS)

计划入组 125 人 · 首次发布于 2013 年 2 月 8 日

药物

查看全部 807 →

Inflammatory Bowel Syndrome (London Pharmaceuticals & Research)

GLP-2 analog (oral, short bowel syndrome)

Small Molecule

Experimental

Otilonium

相关疾病：Gastrointestinal pain, Pain，另有 2 项

C₂₉H₄₃N₂O₄

机构

查看全部 107 →

ALPORT SYNDROME FOUNDATION

United States

International Bowel Ultrasound Group e.V.

Germany

International Rett Syndrome Foundation

United States

资讯

查看全部 9417 →

9个月前

Immuron Secures US Department of Defense Award for Novel Oral Therapeutics Against Military-Priority Pathogens

去年

Anatara Lifesciences Nears Completion of Stage 2 Recruitment for GaRP-IBS Trial

去年

临床试验

Post-Infectious Irritable Bowel Syndrome (PI-IBS)

Gut Microbiome in Patients With Post-infectious Irritable Bowel Syndrome

Microbe-Gut Interaction in Microscopic Colitis and Post-Infectious Irritable Bowel Syndrome (IBS)

药物

Inflammatory Bowel Syndrome (London Pharmaceuticals & Research)

GLP-2 analog (oral, short bowel syndrome)

Otilonium

机构

ALPORT SYNDROME FOUNDATION

International Bowel Ultrasound Group e.V.

International Rett Syndrome Foundation

资讯

Immuron Secures US Department of Defense Award for Novel Oral Therapeutics Against Military-Priority Pathogens

Anatara Lifesciences Nears Completion of Stage 2 Recruitment for GaRP-IBS Trial

Genetic Variants Influence Diet Effectiveness in Irritable Bowel Syndrome